CILPRESSA Trademark

Trademark Overview

On Sunday, May 21, 2017, a trademark application was filed for CILPRESSA with the United States Patent and Trademark Office. The USPTO has given the CILPRESSA trademark a serial number of 87977025. The federal status of this trademark filing is REGISTERED as of Tuesday, October 8, 2019. This trademark is owned by Ipsen Pharma S.A.S.. The CILPRESSA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for pharmaceutical products; research in the field of pharmaceuticals; scientific research for medical purposes; biological, clinical and medical research; clinical trials; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; testing of pharmaceutical products
cilpressa

General Information

Serial Number87977025
Word MarkCILPRESSA
Filing DateSunday, May 21, 2017
Status700 - REGISTERED
Status DateTuesday, October 8, 2019
Registration Number5877320
Registration DateTuesday, October 8, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 2, 2018

Trademark Statements

Goods and ServicesConducting clinical trials for pharmaceutical products; research in the field of pharmaceuticals; scientific research for medical purposes; biological, clinical and medical research; clinical trials; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; testing of pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 25, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIpsen Pharma S.A.S.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBoulogne Billancourt 92100
FR
Party NameIpsen Pharma S.A.S.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBoulogne Billancourt 92100
FR
Party NameIpsen Pharma S.A.S.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBoulogne Billancourt 92100
FR

Trademark Events

Event DateEvent Description
Tuesday, October 8, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, September 4, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, July 23, 2019NOTICE OF ALLOWANCE CANCELLED
Tuesday, September 3, 2019PETITION TO DIRECTOR - DISMISSED
Tuesday, September 3, 2019ASSIGNED TO PETITION STAFF
Tuesday, July 23, 2019TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, May 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 28, 2019EXTENSION 1 GRANTED
Tuesday, May 28, 2019EXTENSION 1 FILED
Tuesday, May 28, 2019TEAS EXTENSION RECEIVED
Tuesday, November 27, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 2, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 2, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 12, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 28, 2018ELECTRONIC RECORD REVIEW COMPLETE
Friday, August 10, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, August 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 9, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 9, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 3, 2018ASSIGNED TO LIE
Tuesday, June 19, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 19, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 19, 2018LETTER OF SUSPENSION E-MAILED
Monday, March 19, 2018SUSPENSION LETTER WRITTEN
Wednesday, March 7, 2018DIVISIONAL PROCESSING COMPLETE
Monday, February 26, 2018DIVISIONAL REQUEST RECEIVED
Tuesday, March 6, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 26, 2018TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, February 21, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, February 21, 2018INQUIRY TO SUSPENSION E-MAILED
Wednesday, February 21, 2018SUSPENSION INQUIRY WRITTEN
Tuesday, January 9, 2018ASSIGNED TO EXAMINER
Monday, August 21, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, August 21, 2017LETTER OF SUSPENSION E-MAILED
Monday, August 21, 2017SUSPENSION LETTER WRITTEN
Monday, August 21, 2017ASSIGNED TO EXAMINER
Thursday, May 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, May 24, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

cilpressa research clinical medical trials field scientific pharmaceuticals products pharmaceutical information